tiprankstipranks
Trending News
More News >
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

TScan Therapeutics (TCRX) Cash flow

Compare
312 Followers

TScan Therapeutics Cash Flow

TCRX's free cash flow for Q3 2025 was $-33.89M. For the 2025 fiscal year, TCRX's free cash flow was decreased by $-50.14M and operating cash flow was $-32.46M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -110.82M$ -61.36M$ -66.50M$ -48.68M$ -3.02M
Investing Cash Flow
$ -52.61M$ -60.76M$ -4.22M$ -9.94M$ -4.24M
Financing Cash Flow
$ 208.76M$ 135.44M$ 29.36M$ 189.67M$ 288.00K
End Cash Position
$ 183.72M$ 138.39M$ 125.06M$ 166.44M$ 34.79M
Free Cash Flow
$ -114.65M$ -64.50M$ -70.73M$ -58.62M$ -7.26M
Currency in USD

TScan Therapeutics Cash Flow